149 related articles for article (PubMed ID: 14768726)
1. Perfusion MR imaging: basic principles and clinical applications.
Cha S
Magn Reson Imaging Clin N Am; 2003 Aug; 11(3):403-13. PubMed ID: 14768726
[TBL] [Abstract][Full Text] [Related]
2. Dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging in pediatric patients.
Cha S
Neuroimaging Clin N Am; 2006 Feb; 16(1):137-47, ix. PubMed ID: 16543089
[TBL] [Abstract][Full Text] [Related]
3. Comparison of three different MR perfusion techniques and MR spectroscopy for multiparametric assessment in distinguishing recurrent high-grade gliomas from stable disease.
Seeger A; Braun C; Skardelly M; Paulsen F; Schittenhelm J; Ernemann U; Bisdas S
Acad Radiol; 2013 Dec; 20(12):1557-65. PubMed ID: 24200483
[TBL] [Abstract][Full Text] [Related]
4. Intracranial mass lesions: dynamic contrast-enhanced susceptibility-weighted echo-planar perfusion MR imaging.
Cha S; Knopp EA; Johnson G; Wetzel SG; Litt AW; Zagzag D
Radiology; 2002 Apr; 223(1):11-29. PubMed ID: 11930044
[TBL] [Abstract][Full Text] [Related]
5. Perfusion MRI (dynamic susceptibility contrast imaging) with different measurement approaches for the evaluation of blood flow and blood volume in human gliomas.
Thomsen H; Steffensen E; Larsson EM
Acta Radiol; 2012 Feb; 53(1):95-101. PubMed ID: 22114021
[TBL] [Abstract][Full Text] [Related]
6. The role of diffusion and perfusion weighted imaging in the differential diagnosis of cerebral tumors: a review and future perspectives.
Svolos P; Kousi E; Kapsalaki E; Theodorou K; Fezoulidis I; Kappas C; Tsougos I
Cancer Imaging; 2014 Apr; 14(1):20. PubMed ID: 25609475
[TBL] [Abstract][Full Text] [Related]
7. [Perfusion MR imaging for initial diagnosis and follow-up of brain tumors].
Le Bas JF; Grand S; Kremer S; Tropres I; Jiang Z; Krainik A; Remy C; Berger F; Benabid AL
Neurochirurgie; 2005 Sep; 51(3-4 Pt 2):287-98. PubMed ID: 16292173
[TBL] [Abstract][Full Text] [Related]
8. [Multi-slice helical CT perfusion imaging in evaluating intracranial neoplasms and tumor-like lesions].
Zhang QB; Feng XY; He HJ; Jiang BD
Zhonghua Zhong Liu Za Zhi; 2007 Feb; 29(2):131-5. PubMed ID: 17645851
[TBL] [Abstract][Full Text] [Related]
9. Quantification of blood flow in brain tumors: comparison of arterial spin labeling and dynamic susceptibility-weighted contrast-enhanced MR imaging.
Warmuth C; Gunther M; Zimmer C
Radiology; 2003 Aug; 228(2):523-32. PubMed ID: 12819338
[TBL] [Abstract][Full Text] [Related]
10. Perfusion MR imaging of an intracranial collision tumor confirmed by image-guided biopsy.
Jun P; Garcia J; Tihan T; McDermott MW; Cha S
AJNR Am J Neuroradiol; 2006 Jan; 27(1):94-7. PubMed ID: 16418364
[TBL] [Abstract][Full Text] [Related]
11. Peritumoral brain regions in gliomas and meningiomas: investigation with isotropic diffusion-weighted MR imaging and diffusion-tensor MR imaging.
Provenzale JM; McGraw P; Mhatre P; Guo AC; Delong D
Radiology; 2004 Aug; 232(2):451-60. PubMed ID: 15215555
[TBL] [Abstract][Full Text] [Related]
12. High-grade gliomas and solitary metastases: differentiation by using perfusion and proton spectroscopic MR imaging.
Law M; Cha S; Knopp EA; Johnson G; Arnett J; Litt AW
Radiology; 2002 Mar; 222(3):715-21. PubMed ID: 11867790
[TBL] [Abstract][Full Text] [Related]
13. [MR and CT perfusion imaging of the brain: principles and clinical applications].
Grand S; Lefournier V; Krainik A; Bessou P; Tropres I; Chabardes S; Hoffmann D; Le Bas JF
J Radiol; 2007 Mar; 88(3 Pt 2):444-71. PubMed ID: 17457257
[TBL] [Abstract][Full Text] [Related]
14. Utility of relative cerebral blood volume mapping derived from perfusion magnetic resonance imaging in the routine follow up of brain tumors.
Siegal T; Rubinstein R; Tzuk-Shina T; Gomori JM
J Neurosurg; 1997 Jan; 86(1):22-7. PubMed ID: 8988077
[TBL] [Abstract][Full Text] [Related]
15. Perfusion and diffusion MR imaging in enhancing malignant cerebral tumors.
Calli C; Kitis O; Yunten N; Yurtseven T; Islekel S; Akalin T
Eur J Radiol; 2006 Jun; 58(3):394-403. PubMed ID: 16527438
[TBL] [Abstract][Full Text] [Related]
16. Hypoxia imaging in brain tumors.
Yetkin FZ; Mendelsohn D
Neuroimaging Clin N Am; 2002 Nov; 12(4):537-52. PubMed ID: 12687910
[TBL] [Abstract][Full Text] [Related]
17. Contribution of dynamic contrast MR imaging to the differentiation between dural metastasis and meningioma.
Kremer S; Grand S; Rémy C; Pasquier B; Benabid AL; Bracard S; Le Bas JF
Neuroradiology; 2004 Aug; 46(8):642-8. PubMed ID: 15232661
[TBL] [Abstract][Full Text] [Related]
18. Paradoxical perfusion metrics of high-grade gliomas with an oligodendroglioma component: quantitative analysis of dynamic susceptibility contrast perfusion MR imaging.
Sunwoo L; Choi SH; Yoo RE; Kang KM; Yun TJ; Kim TM; Lee SH; Park CK; Kim JH; Park SW; Sohn CH; Won JK; Park SH; Kim IH
Neuroradiology; 2015 Nov; 57(11):1111-20. PubMed ID: 26232204
[TBL] [Abstract][Full Text] [Related]
19. Perfusion and permeability MR imaging of gliomas.
Shiroishi MS; Habibi M; Rajderkar D; Yurko C; Go JL; Lerner A; Mogensen MA; Kim PE; Boyko OB; Zee CS; Law M
Technol Cancer Res Treat; 2011 Feb; 10(1):59-71. PubMed ID: 21214289
[TBL] [Abstract][Full Text] [Related]
20. Primary and metastatic intraaxial brain tumors: prospective comparison of multivoxel 2D chemical-shift imaging (CSI) proton MR spectroscopy, perfusion MRI, and histopathological findings in a group of 159 patients.
Bendini M; Marton E; Feletti A; Rossi S; Curtolo S; Inches I; Ronzon M; Longatti P; Di Paola F
Acta Neurochir (Wien); 2011 Feb; 153(2):403-12. PubMed ID: 21165751
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
